However, CCL2 does not seem to activate these cells directly, and genetic CCR2 deletion has been proven to facilitate the progression of neurodegeneration in different mouse models of Alzheimer’s disease [6,7]. Here, CCL2 is linked to early-onset autosomal dominant Alzheimer disease.